1. S77 Transcriptomic studies reveal monocyte-related genes as major contributor to disease activity in pulmonary sarcoidosis. (15th November 2017) Authors: Kendrick, Y; Crawshaw, A; Lockstone, H; Giannoulatou, E; Argoud, K; Taylor, S; Ho, LP Journal: Thorax Issue: Volume 72(2017)Supplement 3 Page Start: A48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. S50 Monocytes from IPF patients show pre-conditioned pro-repair features. (15th November 2016) Authors: Fraser, E; Blirando, K; St.Noble, V; Benamore, R; Hoyles, R; Benlahrech, A; Ho, LP Journal: Thorax Issue: Volume 71(2016)Supplement 3 Page Start: A30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. S78 Lymphopaenia and increased ace levels stratify sarcoidosis patients to underlying increase in IFN-γ + lymphocyte and TNF-α+ monocytes respectively. (15th November 2016) Authors: Kendrick, YK; Cole, SL; Hoyles, R; Ho, LP Journal: Thorax Issue: Volume 71(2016)Supplement 3 Page Start: A45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P284 Identifying patients at risk of acute exacerbation of ipf using the cpi score. (15th November 2016) Authors: Fraser, E; Noble, V St; Benamore, R; Hoyles, R; Ho, LP Journal: Thorax Issue: Volume 71(2016)Supplement 3 Page Start: A243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P39 CTAS – a ct score to quantify disease activity in pulmonary sarcoidosis. (15th November 2016) Authors: Kendrick, YK; Repapi, E; Helm, E; Cole, SL; Hoyles, R; Benamore, R; Ho, LP Journal: Thorax Issue: Volume 71(2016)Supplement 3 Page Start: A103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P175 Single centre experience of the real-life impact of pirfenidone on lung function in patients with idiopathic pulmonary fibrosis. (15th November 2016) Authors: Rathnapala, A; Fries, A; West, Y; Ho, LP; Hoyles, RK Journal: Thorax Issue: Volume 71(2016)Supplement 3 Page Start: A179 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P170 Single centre experience on idiopathic pulmonary fibrosis patient tolerance of pirfenidone; impact on nurse-led ILD helpline usage. (15th November 2016) Authors: Rathnapala, A; Ruggiero, C; Fries, A; Ho, LP; Hoyles, RK Journal: Thorax Issue: Volume 71(2016)Supplement 3 Page Start: A176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. S101 Single centre experience of switching patients with idiopathic pulmonary fibrosis from pirfenidone to nintedanib. (15th November 2016) Authors: Rathnapala, A; Fries, A; Ruggiero, C; Ho, LP; Hoyles, RK Journal: Thorax Issue: Volume 71(2016)Supplement 3 Page Start: A60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. S75 A readily accessible CT-based score to measure amount of fibrosis in IPF. (December 2018) Authors: Fraser, E; St Noble, V; Hoyles, R; Benamore, R; Ho, LP Journal: Thorax Issue: Volume 73(2018)Supplement 4 Page Start: A46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. S96 A combination score of raised sACE, lymphopenia and hypergammaglobulinaemia correlates with active disease on thoracic CT scan of patients with pulmonary sarcoidosis. (19th November 2012) Authors: Kendrick, YR; Helm, EJ; Benamore, R; Ho, LP Journal: Thorax Issue: Volume 67(2012)Supplement 2 Page Start: A47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗